Bill Would Let Copycats Compete With Biotech Drugs - NYTimes.com

Bill Would Let Copycats Compete With Biotech Drugs - NYTimes.com: "The legislation would give the Food and Drug Administration broad discretion to approve copycat versions of complex medicines that are usually made from living cells. Its passage could lead to significant savings for government health programs and private insurers but could hurt large drug makers and result in fewer research incentives.

A version of the legislation that was much friendlier to large drug makers passed the Senate health committee last year but died without being voted on. Emboldened by President Obama’s election and larger Democratic majorities in Congress, consumer advocates pressed for a less industry-friendly bill. They got it."

Related articles by Zemanta

• The Health Reform We Need & Are Not Getting (nybooks.com)
• Newt Gingrich: Obama Has "Already Failed" (VIDEO) (huffingtonpost.com)